Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart GILEAD SCIENCES, INC.
Upcoming events on GILEAD SCIENCES, INC.
12/02/21 | 02:40pm Evercore ISI HealthCONx Conference
12/11/21 | 10:00am American Society of Hematology Virtual Meeting and Exposition - Abstract No - 93
12/11/21 | 05:30pm American Society of Hematology Virtual Meeting and Exposition - Abstract No - 1764
12/11/21 | 05:30pm American Society of Hematology Virtual Meeting and Exposition - Abstract No - 1424
12/11/21 | 05:30pm American Society of Hematology Virtual Meeting and Exposition - Abstract No - 1350
12/12/21 | 09:30am American Society of Hematology Virtual Meeting and Exposition - Abstract No - 371
12/12/21 | 10:15am American Society of Hematology Virtual Meeting and Exposition - Abstract No - 430
12/12/21 | 02:00pm American Society of Hematology Virtual Meeting and Exposition - Abstract No - 2
12/12/21 | 04:45pm American Society of Hematology Virtual Meeting and Exposition - Abstract No - 530
12/12/21 | 06:00pm American Society of Hematology Virtual Meeting and Exposition - Abstract No - 2833
Past events on GILEAD SCIENCES, INC.
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - 680
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - OS 2156
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - PO-772
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No- OS 2155
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - PO-892
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - PO-907
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No- OS 97
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - PO-0940
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - PO-771
11/12/21 American Association for the Study of Liver Diseases The Liver Meeting - Abstract No - PO-803
Past dividends on GILEAD SCIENCES, INC.
09/14/21 Quarterly 0.71 USD
06/14/21 Quarterly 0.71 USD
03/12/21 Quarterly 0.71 USD
12/14/20 Quarterly 0.68 USD
09/14/20 Quarterly 0.68 USD
06/11/20 Quarterly 0.68 USD
03/12/20 Quarterly 0.68 USD
12/12/19 Quarterly 0.63 USD
09/12/19 Quarterly 0.63 USD
06/13/19 Quarterly 0.63 USD
Annual results
Fiscal Period : December201620172018201920202021
Sales
M $
Released
Forecast
Spread
30 390
30 236
0,51%
26 107
25 842
1,0%
22 127
21 839
1,3%
22 449
22 305
0,65%
24 689
24 482
0,84%
 
26 515
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
21 191
20 987
0,97%
17 317
16 841
2,8%
12 840
12 564
2,2%
12 468
13 029
-4,3%
13 184
13 142
0,32%
 
15 243
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
20 033
20 018
0,07%
16 031
16 041
-0,06%
11 411
11 753
-2,9%
11 064
11 571
-4,4%
11 704
11 599
0,90%
 
13 835
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
17 097
17 169
-0,42%
13 529
13 843
-2,3%
7 799
9 060
-14%
5 160
5 333
-3,2%
1 669
1 636
2,0%
 
9 485
 
Net income
M $
Released
Forecast
Spread
13 501
13 570
-0,51%
4 628
10 263
-55%
5 455
7 207
-24%
5 386
4 292
26%
123
137
-10%
 
7 187
 
EPS
$
Released
Forecast
Spread
9,94
10,1
-1,9%
3,51
7,71
-54%
4,17
5,47
-24%
4,22
3,43
23%
0,10
0,12
-16%
 
5,75
 
Announcement Date02/07/201702/06/201802/04/201902/04/202002/04/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $
Released
Forecast
Spread
6 577
6 303
4,3%
7 421
7 174
3,4%
6 423
6 747
-4,8%
6 217
6 084
2,2%
7 421
6 333
17%
 
6 471
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
3 807
3 688
3,2%
3 919
3 997
-1,9%
3 959
4 123
-4,0%
3 695
3 661
0,94%
4 902
3 922
25%
 
3 135
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
3 452
3 130
10%
3 492
3 421
2,1%
3 486
3 629
-3,9%
3 176
3 074
3,3%
4 379
3 126
40%
 
2 817
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
825
1 844
-55%
1 814
1 757
3,2%
2 264
2 909
-22%
1 817
2 257
-20%
3 438
1 953
76%
 
2 023
 
Net income
M $
Released
Forecast
Spread
360
1 577
-77%
1 551
1 434
8,2%
1 729
2 220
-22%
1 522
1 854
-18%
2 592
1 769
47%
 
1 528
 
EPS
$
Released
Forecast
Spread
0,29
1,25
-77%
1,23
1,18
4,7%
1,37
1,75
-22%
1,21
1,43
-15%
2,05
1,37
50%
 
1,16
 
Announcement Date10/28/202002/04/202104/29/202107/29/202110/28/2021-
Previous year Next Year
Upcoming sector events for GILEAD SCIENCES, INC.
More events
Past sector events for GILEAD SCIENCES, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise